Medifast (MED) Updates Q4 Earnings Guidance

Medifast (NYSE:MED) updated its fourth quarter earnings guidance on Tuesday. The company provided earnings per share guidance of $1.15-1.20 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.16. The company issued revenue guidance of $137.3-142.3 million, compared to the consensus revenue estimate of $129.20 million.Medifast also updated its FY 2018 guidance to $4.45-4.50 EPS.

Several research analysts have weighed in on the stock. Zacks Investment Research downgraded shares of Medifast from a strong-buy rating to a hold rating in a report on Wednesday, July 25th. ValuEngine downgraded shares of Medifast from a strong-buy rating to a buy rating in a report on Wednesday, August 8th. Finally, DA Davidson upped their price objective on shares of Medifast to $249.00 and gave the stock a buy rating in a report on Friday, August 3rd.

MED traded up $0.92 during trading on Tuesday, hitting $214.88. 267,430 shares of the company’s stock were exchanged, compared to its average volume of 205,319. The company has a market cap of $2.53 billion, a price-to-earnings ratio of 93.83, a PEG ratio of 2.35 and a beta of 0.54. Medifast has a fifty-two week low of $60.69 and a fifty-two week high of $260.98.

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 8th. Stockholders of record on Friday, September 21st will be issued a $0.48 dividend. The ex-dividend date of this dividend is Thursday, September 20th. This represents a $1.92 annualized dividend and a dividend yield of 0.89%. Medifast’s dividend payout ratio is currently 83.84%.

WARNING: “Medifast (MED) Updates Q4 Earnings Guidance” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this report on another website, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The correct version of this report can be read at https://www.dispatchtribunal.com/2018/11/06/medifast-med-updates-q4-earnings-guidance.html.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by OPTAVIA, Flavors of Home, and Essential 1 brands.

Featured Article: What is the Ex-Dividend Date in Investing?

Earnings History and Estimates for Medifast (NYSE:MED)

Receive News & Ratings for Medifast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medifast and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply